Supplementary Figure S3 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplementary Figure S3 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer2024
2. 2Supplementary Figure S6 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer2024
3. 3Supplementary Figure S6 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer2024
4. 4Supplementary Figure S8 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer2024
5. 5Supplementary Figure S8 from Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer2024